Literature DB >> 12905459

Tuberculosis in the cytokine era: what rheumatologists need to know.

Carol Dukes Hamilton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12905459     DOI: 10.1002/art.11134

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  5 in total

1.  Miliary tuberculosis after infliximab therapy in Lebanon.

Authors:  Imad Uthman; Nadim Kanj; Jinane El-Sayad; Abdul-Rahman Bizri
Journal:  Clin Rheumatol       Date:  2004-04-16       Impact factor: 2.980

Review 2.  Immunosuppression related to collagen-vascular disease or its treatment.

Authors:  Carol Dukes Hamilton
Journal:  Proc Am Thorac Soc       Date:  2005

3.  Comparison of in vitro-specific blood tests with tuberculin skin test for diagnosis of latent tuberculosis before anti-TNF therapy.

Authors:  Jérémie Sellam; Haifa Hamdi; Carine Roy; Gabriel Baron; Marc Lemann; Xavier Puéchal; Maxime Breban; Francis Berenbaum; Marc Humbert; Karin Weldingh; Dominique Salmon; Philippe Ravaud; Dominique Emilie; Xavier Mariette
Journal:  Ann Rheum Dis       Date:  2007-04-24       Impact factor: 19.103

4.  Positiveness of purified protein derivatives in rheumatoid arthritis patients who are not receiving immunosuppressive therapy.

Authors:  Ilhan Sezer; Hilal Kocabas; Meltem Alkan Melikoglu; Mehmet Arman
Journal:  Clin Rheumatol       Date:  2008-08-08       Impact factor: 2.980

5.  MicroRNA-889 Inhibits Autophagy To Maintain Mycobacterial Survival in Patients with Latent Tuberculosis Infection by Targeting TWEAK.

Authors:  Der-Yuan Chen; Yi-Ming Chen; Chin-Fu Lin; Che-Min Lo; Hung-Jen Liu; Tsai-Ling Liao
Journal:  mBio       Date:  2020-01-28       Impact factor: 7.867

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.